GoggleDocs (@goggledocs) 's Twitter Profile
GoggleDocs

@goggledocs

🥽🩺Docs/nurses/pharmacists from U.K. Talking CardioRenoMetabolic & more Catch us on YouTube youtube.com/c/GoggleDocs |Educate, Motivate, Activate!

ID: 1313928734144188419

calendar_today07-10-2020 19:46:43

2,2K Tweet

3,3K Takipçi

2,2K Takip Edilen

GoggleDocs (@goggledocs) 's Twitter Profile Photo
GoggleDocs
@goggledocs

a month ago

📢 Tirzepatide vs Semaglutide: the heavyweight match lands hard 🔹 72w RCT in obesity (no T2D): – Tirzepatide ⤵️ –20.2% – Semaglutide ⤵️ –13.7% 🔸 Waist ⤵️ –18.4cm vs –13.0cm 🔹 More likely to hit ⩾25% loss: 32% vs 16% 🔸 GI AEs common, but discontinuation <10% 👉 Dual

📢 Tirzepatide vs Semaglutide: the heavyweight match lands hard 🔹 72w RCT in obesity (no T2D): – Tirzepatide ⤵️ –20.2% – Semaglutide ⤵️ –13.7% 🔸 Waist ⤵️ –18.4cm vs –13.0cm 🔹 More likely to hit ⩾25% loss: 32% vs 16% 🔸 GI AEs common, but discontinuation &lt;10% 👉 Dual